Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Diabetogenic Action of Alloxan Derivatives

Abstract

THE finding of Shaw-Dunn and co-workers1 that alloxan (and a styryl-quinoline) causes diabetes by damaging the pancreatic islet cells has since been amply confirmed in a number of laboratories, working with various animal species. Attempts to discover other substances with similar action have so far been unsuccessful, nor has any explanation been offered regarding the mechanism by which alloxan attacks the β-islet cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shaw-Dunn, J., Sheehan, H. L., and McLetchie, N. G. B., Lancet, 244, 484 (1943).

  2. Jacobs, H. R., Proc. Soc. Exp. Biol. Med., 37, 407 (1937).

    Article  Google Scholar 

  3. Goldner, M. G., and Gomori, G., Endocrinology, 35, 241 (1944).

    Article  CAS  Google Scholar 

  4. Thorogood, C., Federation Proc., 3, 48 (1944).

    Google Scholar 

  5. Strecker, A., Ann. Chem., 123, 363 (1862).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BRÜCKMANN, G., WERTHEIMER, E. Diabetogenic Action of Alloxan Derivatives. Nature 155, 267–268 (1945). https://doi.org/10.1038/155267b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/155267b0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing